Early Use of IL-6 Inhibitors May Improve COVID-19 Outcomes
Mortality, risk for intubation lower with IL6ri use in severe COVID-19 stage IIB versus stage III
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.